Invokana Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Cognitive Protective Effect of Newer Antidiabetic Drugs
Condition:   Type 2 Diabetes Interventions:   Drug: Dapagliflozin;   Drug: Empagliflozin;   Drug: Canagliflozin;   Drug: Sitagliptin;   Drug: Saxagliptin;   Drug: Linagliptin;   Drug: Vildagliptin Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Safety and Efficacy of Canagliflozin in Advanced CKD
Conditions:   ESRD;   CKD Stage 4;   CKD Stage 5 Intervention:   Drug: Invokana 300 mg and 100 mg tablet Sponsor:   McGill University Health Centre/Research Institute of the McGill University Health Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2022 Category: Research Source Type: clinical trials